Connect with us

Headline News

Jennifer Keesmaat reveals her new Toronto development plan

Published

on

Former chief city planner Jennifer Keesmaat, co-founder of Markee Developments, has revealed the details for her new (and first) community development in North York on the site of historic Tyndale University.

The 22-acre site is currently home to a private university with one main building along with ancillary uses and surface parking. It backs onto German Mills Creek, a tributary of the Don River.

According to the project submission, dated June 13, the proposal would permit “15 buildings (with 19 building components) across the three-phased development areas. Most of the buildings range in height from 5 to 8 storeys, with three buildings from 12 to 20 storeys. These buildings will accommodate 1,504 units, comprised of 752 affordable units (the remaining at market rates) that will remain affordable in perpetuity.”

In addition, according to City of Toronto information, the application states that “Tyndale University would own the residential components and would remain operational.”

But the site will be more than housing. It will be a complete community, according to Keesmaat, who spoke with Post City when the project was announced.

We are thrilled to announce Tyndale Green: a new rental housing community by Markee Developments in partnership with Tyndale University. All the good things: an extension of the ravine landscape, a new community hub & cafe, a new daycare, shared streets and 752 affordable homes. pic.twitter.com/dYqSwP2Tkh

— Jennifer Keesmaat (@jen_keesmaat) June 17, 2021

“This site presents an opportunity to create something that doesn’t exist today, and that is a community hub,” said Keesmaat, “and a community where you can do a series of things within walking distance, including for the existing neighbourhood today. There will be a coffee shop on our site and a bookstore and a daycare. There will be amenities within walking distance where they don’t exist today.”

The site will also be close to transit, including the Sheppard subway, and Keesmaat envisions separated bike lanes along Bayview Avenue.

“Bayview has a significant amount of space that could be allocated to a cycling lane,” she said. “It’s really only a short bike ride to higher-order transit on Sheppard if you have that separated bike lane. But right now there isn’t a bike lane.”

Keesmaat said it is important to note that the “majority of the site will not be developed.”

“Part of what we want to do here is thinking really carefully about how we can add some density in a very careful way while creating a community hub that respects the ravine landscape,” she said.

The next step for the project will be a preliminary report to North York Community Council.

Continue Reading

Headline News

6 fully vaccinated people who attended an outdoor wedding caught the Delta variant, but people with Pfizer and Moderna shots survived, study says

Published

on

Six fully vaccinated people who attended an outdoor wedding in Texas in April came down with COVID-19, a new study says – a small outbreak that underscores how effective US-authorized vaccines are against even variants of the virus.Though the vaccines made by Pfizer and Moderna may not knock out every COVID-19 case, especially now that the more infectious Delta variant dominates across the US, they are very good at preventing death from COVID-19.

The preprint study from Baylor College of Medicine found that only one person who’d gotten an Indian-made vaccine, Covaxin, died after attending the 92-person wedding near Houston.

The wedding took place in a “large, open-air tent” before the Delta variant was circulating widely in the US. Guests were required to be fully vaccinated at the event, though that policy operated on the honor system.

The study’s authors said they suspect the Delta variant was introduced at the wedding by two people who had traveled from India and tested negative before their flight but developed symptoms in the US. All the COVID-19 patients said they’d had close encounters with those two people during the wedding, according to the study.

Continue Reading

Headline News

5,946 Fatalities Reported Related to COVID-19 Vaccination

Published

on

(Precision Vaccinations)

The US Centers for Disease Control and Prevention (CDC) confirmed on July 7, 2021, the Vaccine Adverse Events Reporting System (VAERS) had received 5,946 reports of death among people who received a COVID-19 vaccine.

However, a review of available clinical information, including death certificates, autopsy, and medical records, has not established a causal link to COVID-19 vaccines, says the CDC’s website.

This CDC data indicates a vaccine fatality rate of about (0.0018%) since over 331 million vaccinations have been completed in the USA since December 2020.

The U.S. FDA requires healthcare providers to report any death after a COVID-19 vaccination to VAERS, even if it’s unclear whether the vaccine was the cause. Reports of adverse events to VAERS following vaccination, including deaths, do not necessarily mean that a vaccine caused a health problem.

VAERS is co-sponsored by the CDC, and the FDA, agencies of the U.S. Department of Health and Human Services.

Continue Reading

Headline News

Selected Adverse Events Reported after COVID-19 Vaccination

Published

on

What You Need to Know

  • COVID-19 vaccines are safe and effective.
  • Millions of people in the United States have received COVID-19 vaccines under the most intense safety monitoring in U.S. history.
  • CDC recommends everyone 12 years and older get vaccinated as soon as possible to help protect against COVID-19 and the related, potentially severe complications that can occur.
  • CDC, the U.S. Food and Drug Administration (FDA), and other federal agencies are monitoring the safety of COVID-19 vaccines.
  • Adverse events described on this page have been reported to the Vaccine Adverse Event Reporting System (VAERS)external icon.
  • VAERS accepts reports of any adverse event following any vaccination.
  • Reports of adverse events to VAERS following vaccination, including deaths, do not necessarily mean that a vaccine caused a health problem.

For public awareness and in the interest of transparency, CDC is providing timely updates on the following serious adverse events of interest:

  • Anaphylaxis after COVID-19 vaccination is rare and has occurred in approximately 2 to 5 people per million vaccinated in the United StatesSevere allergic reactions, including anaphylaxis, can occur after any vaccination. If this occurs, vaccination providers can effectively and immediately treat the reaction. Learn more about COVID-19 vaccines and allergic reactions, including anaphylaxis.
  • Thrombosis with thrombocytopenia syndrome (TTS) after Johnson & Johnson’s Janssen (J&J/Janssen) COVID-19 vaccination is rare. As of July 12, 2021, more than 12.8 million doses of the J&J/Janssen COVID-19 Vaccine have been given in the United States. CDC and FDA identified 38 confirmed reports of people who got the J&J/Janssen COVID-19 Vaccine and later developed TTS. Women younger than 50 years old especially should be aware of the rare but increased risk of this adverse event. There are other COVID-19 vaccine options available for which this risk has not been seen. Learn more about J&J/Janssen COVID-19 Vaccine and TTS.
    • To date, two confirmed cases of TTS following mRNA COVID-19 vaccination (Moderna) have been reported to VAERS after more than 321 million doses of mRNA COVID-19 vaccines administered in the United States. Based on available data, there is not an increased risk for TTS after mRNA COVID-19 vaccination.
  • CDC and FDA are monitoring reports of Guillain-Barré Syndrome (GBS) in people who have received the J&J/Janssen COVID-19 Vaccine. GBS is a rare disorder where the body’s immune system damages nerve cells, causing muscle weakness and sometimes paralysis. Most people fully recover from GBS, but some have permanent nerve damage. After 12.8 million J&J/Janssen COVID-19 Vaccine doses administered, there have been around 100 preliminary reports of GBS identified in VAERS. These cases have largely been reported about 2 weeks after vaccination and mostly in men, many 50 years and older. CDC will continue to monitor for and evaluate reports of GBS occurring after COVID-19 vaccination and will share more information as it becomes available.
  • Myocarditis and pericarditis after COVID-19 vaccination are rare. As of July 12, 2021, VAERS has received 1,047 reports of myocarditis or pericarditis among people ages 30 and younger who received a COVID-19 vaccine. Most cases have been reported after mRNA COVID-19 vaccination (Pfizer-BioNTech or Moderna), particularly in male adolescents and young adults. Through follow-up, including medical record reviews, CDC and FDA have confirmed 633 reports of myocarditis or pericarditis. CDC and its partners are investigating these reports to assess whether there is a relationship to COVID-19 vaccination. Learn more about COVID-19 vaccines and myocarditis.
  • Reports of death after COVID-19 vaccination are rare. More than 334 million doses of COVID-19 vaccines were administered in the United States from December 14, 2020, through July 12, 2021. During this time, VAERS received 6,079 reports of death (0.0018%) among people who received a COVID-19 vaccine. FDA requires healthcare providers to report any death after COVID-19 vaccination to VAERS, even if it’s unclear whether the vaccine was the cause. Reports of adverse events to VAERS following vaccination, including deaths, do not necessarily mean that a vaccine caused a health problem. A review of available clinical information, including death certificates, autopsy, and medical records, has not established a causal link to COVID-19 vaccines. However, recent reports indicate a plausible causal relationship between the J&J/Janssen COVID-19 Vaccine and TTS, a rare and serious adverse event—blood clots with low platelets—which has caused deaths.
Continue Reading

Trending